Status:
UNKNOWN
Case Series Study to Detect SARS-CoV-2 in Semen of COVID-19 Patients
Lead Sponsor:
Igenomix
Conditions:
SARS-CoV-2
Eligibility:
MALE
18-65 years
Brief Summary
A descriptive, clinical series, single-centre, national, biomedical study to determine the presence of SARS-CoV-2 in sperm samples from positive PCR patients for COVID-19 and to evaluate the presence ...
Detailed Description
In late December 2019, a new coronavirus strain emerged in China causing coronavirus disease 2019 (COVID19). Since then, COVID19 has become a global pandemic outbreak being declared a "public health e...
Eligibility Criteria
Inclusion
- Patients whose written informed consent approved by the Ethics Committee (EC) has been obtained, after having been duly informed of the nature of the study and voluntarily accepted to participate after being fully aware of the potential risks, benefits and any discomfort involved.
- Male age: 18 - 65 years, both included.
- COVID-19 positive result by PCR (including symptomatic and asymptomatic subjects).
Exclusion
- Patients with severe symptoms or any other medical condition that is unstable or which, according to medical criteria, may put at risk the patient's safety and his compliance in the study
- Known medical history of azoospermia or anejaculation
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04717011
Start Date
February 1 2021
End Date
July 1 2021
Last Update
February 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Ruber Internacional
Madrid, Spain, 28034